Robert A Sokolic

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. doi request reprint Neutropenia in primary immunodeficiency
    Robert Sokolic
    Disorders of Immunity Section, Genetics and Molecular Biology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland 20892 1611, USA
    Curr Opin Hematol 20:55-65. 2013
  2. pmc Nonmyeloablative conditioning with busulfan before matched littermate bone marrow transplantation results in reversal of the disease phenotype in canine leukocyte adhesion deficiency
    Robert A Sokolic
    Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    Biol Blood Marrow Transplant 11:755-63. 2005
  3. pmc Myeloid dysplasia and bone marrow hypocellularity in adenosine deaminase-deficient severe combined immune deficiency
    Robert Sokolic
    Disorders of Immunity Section, Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda, MD 20892, USA
    Blood 118:2688-94. 2011
  4. ncbi request reprint Nonmyeloablative hematopoietic stem cell transplantation corrects the disease phenotype in the canine model of leukocyte adhesion deficiency
    Thomas R Bauer
    Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 1203, USA
    Exp Hematol 33:706-12. 2005
  5. pmc Correction of the disease phenotype in canine leukocyte adhesion deficiency using ex vivo hematopoietic stem cell gene therapy
    Thomas R Bauer
    Experimental Transplantation and Immunology Branch, National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC1203, Bldg 10 CRC, Rm 3 3264, Bethesda, MD 20892 1203, USA
    Blood 108:3313-20. 2006
  6. ncbi request reprint Leukocyte adhesion deficiency in children and Irish setter dogs
    Thomas R Bauer
    Experimental Transplantation and Immunology Branch, National Cancer Institute, National Institutes of Health, 10 Center MSC1907, Building 10, Room 12C116, Bethesda, MD 20892, USA
    Pediatr Res 55:363-7. 2004
  7. ncbi request reprint Myeloid ELF1-like factor is a potent activator of interleukin-8 expression in hematopoietic cells
    Cyrus V Hedvat
    Laboratory of Molecular Aspects of Hematopoiesis, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Biol Chem 279:6395-400. 2004

Detail Information

Publications7

  1. doi request reprint Neutropenia in primary immunodeficiency
    Robert Sokolic
    Disorders of Immunity Section, Genetics and Molecular Biology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland 20892 1611, USA
    Curr Opin Hematol 20:55-65. 2013
    ..Recent developments in the understanding of neutropenia in several of the PIDDs make a review of the data timely...
  2. pmc Nonmyeloablative conditioning with busulfan before matched littermate bone marrow transplantation results in reversal of the disease phenotype in canine leukocyte adhesion deficiency
    Robert A Sokolic
    Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    Biol Blood Marrow Transplant 11:755-63. 2005
    ..These results indicate that a nonmyeloablative conditioning regimen with chemotherapy alone is capable of generating stable mixed chimerism and reversal of the disease phenotype in CLAD...
  3. pmc Myeloid dysplasia and bone marrow hypocellularity in adenosine deaminase-deficient severe combined immune deficiency
    Robert Sokolic
    Disorders of Immunity Section, Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda, MD 20892, USA
    Blood 118:2688-94. 2011
    ..These trials were registered at www.clinicaltrials.gov as #NCT00018018 and #NCT00006319...
  4. ncbi request reprint Nonmyeloablative hematopoietic stem cell transplantation corrects the disease phenotype in the canine model of leukocyte adhesion deficiency
    Thomas R Bauer
    Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 1203, USA
    Exp Hematol 33:706-12. 2005
    ....
  5. pmc Correction of the disease phenotype in canine leukocyte adhesion deficiency using ex vivo hematopoietic stem cell gene therapy
    Thomas R Bauer
    Experimental Transplantation and Immunology Branch, National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC1203, Bldg 10 CRC, Rm 3 3264, Bethesda, MD 20892 1203, USA
    Blood 108:3313-20. 2006
    ....
  6. ncbi request reprint Leukocyte adhesion deficiency in children and Irish setter dogs
    Thomas R Bauer
    Experimental Transplantation and Immunology Branch, National Cancer Institute, National Institutes of Health, 10 Center MSC1907, Building 10, Room 12C116, Bethesda, MD 20892, USA
    Pediatr Res 55:363-7. 2004
    ....
  7. ncbi request reprint Myeloid ELF1-like factor is a potent activator of interleukin-8 expression in hematopoietic cells
    Cyrus V Hedvat
    Laboratory of Molecular Aspects of Hematopoiesis, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Biol Chem 279:6395-400. 2004
    ..MEF overexpression is sufficient to induce IL-8 protein expression, and reduction in MEF expression (using RNA interference) results in decreased IL-8 levels. These data demonstrates that MEF is an important regulator of IL-8 expression...